Annual long term liabilities:
$0.00-$67.00K(-100.00%)Summary
- As of today (July 11, 2025), ELVN annual total long term liabilities is $0.00, with the most recent change of -$67.00 thousand (-100.00%) on December 31, 2024.
- During the last 3 years, ELVN annual long term liabilities has fallen by -$150.46 million (-100.00%).
- ELVN annual long term liabilities is now -100.00% below its all-time high of $150.46 million, reached on December 31, 2021.
Performance
ELVN Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$302.00K+$302.00K(+100.00%)Summary
- As of today (July 11, 2025), ELVN quarterly total long term liabilities is $302.00 thousand, with the most recent change of +$302.00 thousand (+100.00%) on March 31, 2025.
- Over the past year, ELVN quarterly long term liabilities has increased by +$268.00 thousand (+788.24%).
- ELVN quarterly long term liabilities is now -99.80% below its all-time high of $150.56 million, reached on September 30, 2022.
Performance
ELVN quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ELVN Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +788.2% |
| 3 y3 years | -100.0% | - |
| 5 y5 years | -100.0% | -99.8% |
ELVN Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -99.8% | >+9999.0% |
| 5 y | 5-year | -100.0% | at low | -99.8% | >+9999.0% |
| alltime | all time | -100.0% | at low | -99.8% | >+9999.0% |
ELVN Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $302.00K(>+9900.0%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $6000.00(-82.4%) |
| Mar 2024 | - | $34.00K(-49.3%) |
| Dec 2023 | $67.00K | $67.00K(-68.7%) |
| Sep 2023 | - | $214.00K(-40.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $360.00K(-29.1%) |
| Mar 2023 | - | $508.00K(-99.7%) |
| Dec 2022 | $150.41M(-0.0%) | $150.41M(-0.1%) |
| Sep 2022 | - | $150.56M(+0.1%) |
| Dec 2021 | $150.46M(+0.4%) | - |
| Dec 2021 | - | $150.46M |
| Dec 2020 | $149.83M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Enliven Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of ELVN is $0.00
What is the all time high annual long term liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual total long term liabilities is $150.46M
What is Enliven Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, ELVN annual total long term liabilities has changed by -$67.00K (-100.00%)
What is Enliven Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of ELVN is $302.00K
What is the all time high quarterly long term liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly total long term liabilities is $150.56M
What is Enliven Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, ELVN quarterly total long term liabilities has changed by +$268.00K (+788.24%)